CNS (Blood brain barrier)

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\CNS (Blood brain barrier).php on line 2
CNS (Blood brain barrier)

LE WE PMID CA

CNS (Blood brain barrier)

1195

ZNS (Hirnschranke)

Adrenomedullin

Aids

Antibiotics (BASKET)

Antibodies (therapeutic use)

Blood vessels (Permeability)

Blood vessels (Physiology)

Claudin5

CNS (Blood brain barrier)

CNS (Metabolism of injured CNS)

Drug delivery

Immune privilege

Kidney (Uremic toxin)

Nervous system (Neurodegeneration)

Neurovascular unit

SLC22A3 OCT3

SLC6A6 Taut Taurin

SLC6A8 CRT Creatine

Tight junction

Transporter (ABC family)

Transporter (Organic molecules)

Ultrasound (Toxicity and therapeutic use)

2009 1	The blood-brain barrier in neurodegenerative disease: a rhetorical perspective. [19659460] J Neurochem 111(2): 291-314 (2009)
1998 2	CNS drug design based on principles of blood-brain barrier transport. [9572261] J Neurochem 70(5): 1781-92 (1998)
2010 3	Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage. [20087366] J Cereb Blood Flow Metab 30(4): 689-702 (2010)
1988 4	Mediators of blood-brain barrier dysfunction and formation of vasogenic brain edema. [2843554] J Cereb Blood Flow Metab 8(5): 621-34 (1988)
2009 5	Mechanisms of the penetration of blood-borne substances into the brain. [19949573] Curr Neuropharmacol 7(2): 142-9 (2009)
2008 6	Intranasal administration of acetylcholinesterase inhibitors. [19091003] BMC Neurosci 9 Suppl 3(-): S6 (2008)
2008 7	Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. [19091002] BMC Neurosci 9 Suppl 3(-): S5 (2008)
2008 8	Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS. [19091001] BMC Neurosci 9 Suppl 3(-): S4 (2008)
2008 9	Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease. [19090999] BMC Neurosci 9 Suppl 3(-): S2 (2008)
2009 10	Characteristics of compounds that cross the blood-brain barrier. [19534732] BMC Neurol 9 Suppl 1(-): S3 (2009)
2006 11	Trojan horse or proton force: finding the right partner(s) for toxin translocation. [16785102] Neurotox Res 9(2-3): 63-71 (2006)
2005 12	The blood-brain barrier/neurovascular unit in health and disease. [15914466] Pharmacol Rev 57(2): 173-85 (2005)
1997 13	The blood-brain barrier in neuroinflammatory diseases. [9228664] Pharmacol Rev 49(2): 143-55 (1997)
2004 14	New aspects of the blood-brain barrier transporters; its physiological roles in the central nervous system. [15467183] Biol Pharm Bull 27(10): 1489-96 (2004)
2008 15	Postulated role of vasoactive neuropeptide-related immunopathology of the blood brain barrier and Virchow-Robin spaces in the aetiology of neurological-related conditions. [19229345] Mediators Inflamm 2008(-): 792428 (2008)
2009 16	The gut immune barrier and the blood-brain barrier: are they so different? [19836264] Immunity 31(5): 722-35 (2009)
2004 17	Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. [14612429] J Leukoc Biol 75(3): 388-97 (2004)
2000 18	Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia. [10985259] J Leukoc Biol 68(3): 413-22 (2000)
2007 19	The blood-brain barrier and cancer: transporters, treatment, and Trojan horses. [17363519] Clin Cancer Res 13(6): 1663-74 (2007)
2006 20	The dam breaks: disruption of the blood-brain barrier in diabetes mellitus. [16877556] Am J Physiol Heart Circ Physiol 291(6): H2595-6 (2006)
1985 21	The blood-brain barrier. Transport across the cerebral endothelium. [2410161] Circ Res 57(2): 213-22 (1985)
2000 22	The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery. [11302254] Neuro Oncol 2(1): 45-59 (2000)
2005 23	Blood-brain barrier genomics, proteomics, and new transporter discovery. [15717066] NeuroRx 2(1): 151-61 (2005)
2005 24	Drug transport to brain with targeted liposomes. [15717061] NeuroRx 2(1): 99-107 (2005)
2005 25	Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. [15717060] NeuroRx 2(1): 86-98 (2005)
2005 26	Active efflux across the blood-brain barrier: role of the solute carrier family. [15717059] NeuroRx 2(1): 73-85 (2005)
2005 27	Brain-to-blood transporters for endogenous substrates and xenobiotics at the blood-brain barrier: an overview of biology and methodology. [15717058] NeuroRx 2(1): 63-72 (2005)
2005 28	Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems. [15717057] NeuroRx 2(1): 54-62 (2005)
2005 29	Development of neuropeptide drugs that cross the blood-brain barrier. [15717056] NeuroRx 2(1): 44-53 (2005)
2005 30	Localization of brain endothelial luminal and abluminal transporters with immunogold electron microscopy. [15717055] NeuroRx 2(1): 27-43 (2005)
2005 31	How to measure drug transport across the blood-brain barrier. [15717054] NeuroRx 2(1): 15-26 (2005)
2004 32	Cell therapy in Huntington's disease. [15717043] NeuroRx 1(4): 394-405 (2004)
2010 33	Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. [20413754] Radiology 255(2): 415-25 (2010)
2006 34	Imaging and nanomedicine for diagnosis and therapy in the central nervous system: report of the eleventh annual Blood-Brain Barrier Disruption Consortium meeting. [16552023] AJNR Am J Neuroradiol 27(3): 715-21 (2006)
2002 35	Advances in the understanding of the blood-brain barrier in neuro-oncology. [12427643] AJNR Am J Neuroradiol 23(10): 1807-10 (2002)
2006 36	CNS drug delivery: opioid peptides and the blood-brain barrier. [16584136] AAPS J 8(1): E76-88 (2006)
2008 37	Recent advances in blood-brain barrier disruption as a CNS delivery strategy. [18446517] AAPS J 10(1): 166-77 (2008)
2002 38	Peptide delivery to the brain via adsorptive-mediated endocytosis: advances with SynB vectors. [12645998] AAPS PharmSci 4(4): E26 (2002)
2008 39	Ultrasound for drug and gene delivery to the brain. [18486271] Adv Drug Deliv Rev 60(10): 1209-17 (2008)
2011 40	In vitro models of the blood-brain barrier. [21499332] Acta Neurobiol Exp (Wars) 71(1): 113-28 (2011)
2007 41	Neuron-glial interactions in blood-brain barrier formation. [17506642] Annu Rev Neurosci 30(-): 235-58 (2007)
2010 42	Mouse models of neurological disorders: a view from the blood-brain barrier. [19879356] Biochim Biophys Acta 1802(10): 881-8 (2010)
2009 43	Pericyte signaling in the neurovascular unit. [19064799] Stroke 40(3 Suppl): S13-5 (2009)
2003 44	Holey barrier: claudins and the regulation of brain endothelial permeability. [12743096] J Cell Biol 161(3): 459-60 (2003)
2010 45	Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. [20930076] Clin Microbiol Rev 23(4): 858-83 (2010)
2008 46	Physiology and pharmacological role of the blood-brain barrier. [19066407] Pharmacol Rep 60(5): 600-22 (2008)
2002 47	Astrocyte-endothelial interactions and blood-brain barrier permeability. [12162730] J Anat 200(6): 629-38 (2002)
2002 48	Blood-brain barrier breakdown in septic encephalopathy and brain tumours. [12162731] J Anat 200(6): 639-46 (2002)
2008 49	Brain endothelial cell-cell junctions: how to "open" the blood brain barrier. [19506719] Curr Neuropharmacol 6(3): 179-92 (2008)
2010 50	Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier. [20417575] Trends Pharmacol Sci 31(6): 246-54 (2010)
2011 51	Monoclonal antibodies in neuro-oncology: Getting past the blood-brain barrier. [21150307] MAbs 3(2): 153-60 (2011)
2003 52	Adrenomedullin, an autocrine mediator of blood-brain barrier function. [12630813] Hypertens Res 26 Suppl(-): S61-70 (2003)
2008 53	Progress and problems in the application of focused ultrasound for blood-brain barrier disruption. [18511095] Ultrasonics 48(4): 279-96 (2008)
2011 54	Transport characteristics of guanidino compounds at the blood-brain barrier and blood-cerebrospinal fluid barrier: relevance to neural disorders. [21352605] Fluids Barriers CNS 8(1): 13 (2011)
2011 55	Fluids and barriers of the CNS: a historical viewpoint. [21349150] Fluids Barriers CNS 8(1): 2 (2011)
2011 56	Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences. [21349151] Fluids Barriers CNS 8(1): 3 (2011)
2011 57	Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle. [21349152] Fluids Barriers CNS 8(1): 4 (2011)
2010 58	Molecular mechanisms of neuroinvasion by monocytes-macrophages in HIV-1 infection. [20374632] Retrovirology 7(-): 30 (2010)
2006 59	Blood-neural barrier: intercellular communication at glio-vascular interface. [16889675] J Biochem Mol Biol 39(4): 339-45 (2006)
2008 60	The blood-brain barrier: connecting the gut and the brain. [18486244] Regul Pept 149(1-3): 11-4 (2008)
2010 61	Targeted drug delivery across the blood-brain barrier using ultrasound technique. [21785679] Ther Deliv 1(6): 819-48 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\CNS (Blood brain barrier).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\CNS (Blood brain barrier).php on line 92